ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Surgery for Stage IIIa N2 Disease

Monday, November 13, 2017

Mathisen, Douglas; Rendina, Erino; Harling, Leanne (2017): Surgery for Stage IIIa N2 Disease. 
CTSNet, Inc. https://doi.org/10.25373/ctsnet.5588737
Retrieved: 20:35, Nov 13, 2017 (GMT)

Filmed at the 2016 EACTS Annual Meeting in Barcelona, Spain, Leanne Harling of Imperial College in London, UK, moderates a discussion on the role of surgical therapy for N2 lung cancer. Doug Mathisen of Massachusettes General Hospital in Boston, Massachusetts, and Erino Rendina of the University La Sapienza in Rome, Italy, share and debate their approaches to staging, adjuvant therapy, persistent disease, and surgical removal of the primary tumor.

Comments

GREAT DISCUSSION. WHAT ABOUT ABSOLUTE VISUAL CLEARANCE OF ALL N2 nodes. I think it’s got a role along with adjuvant Chemo n Radiotherapy

Add comment

Log in or register to post comments